Water → 3-[((3S)-3-Methyl-4-{[4-(trifluoromethyl)phenyl]sulfonyl}-1-piperazinyl)carbonyl]pyrazolo[1,5-a]pyrimidine
Reaktionsgleichung
Cl.[CH3:2][C@H:3]1[CH2:8][NH:7][CH2:6][CH2:5][N:4]1[S:9]([C:12]1[CH:17]=[CH:16][C:15]([C:18]([F:21])([F:20])[F:19])=[CH:14][CH:13]=1)(=[O:11])=[O:10].C1C=CC2N(O)N=NC=2C=1.O.CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.[N:57]1[N:61]2[CH:62]=[CH:63][CH:64]=[N:65][C:60]2=[C:59]([C:66](O)=[O:67])[CH:58]=1.CCN(C(C)C)C(C)C>C1COCC1>[CH3:2][C@@H:3]1[N:4]([S:9]([C:12]2[CH:13]=[CH:14][C:15]([C:18]([F:21])([F:19])[F:20])=[CH:16][CH:17]=2)(=[O:11])=[O:10])[CH2:5][CH2:6][N:7]([C:66]([C:59]2[CH:58]=[N:57][N:61]3[CH:62]=[CH:63][CH:64]=[N:65][C:60]=23)=[O:67])[CH2:8]1Komponenten
Edukt 6
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
To a solution of (2S)-2-methyl-1-{[4-(trifluoromethyl)phenyl]sulfonyl}piperazine hydrochloride (may be prepared as described in Description 6) (100 mg, 0.270 mmol) in THF (5 ml) was added HOBT.H2O (41.3 mg, 0.270 mmol), HBTU (102 mg, 0.270 mmol) and pyrazolo[1,5-a]pyrimidine-3-carboxylic acid (48.4 mg, 0.297 mmol). The mixture was stirred for 5 minutes before addition of DIPEA (0.118 ml, 0.674 mmol) and the resultant solution stirred at rt for 16 hours. The mixture was then concentrated and the residue partitioned between DCM (10 ml) and water (10 ml), the layers were separated using a hydrophobic frit and the organic layers concentrated to dryness and the crude material dissolved in DMSO and purified by MDAP to give the title compound (85.3 mg) as a white solid.
Aufarbeitung
- concentrationThe mixture was then concentrated
- customthe residue partitioned between DCM (10 ml) and water (10 ml)
- customthe layers were separated
- concentrationthe organic layers concentrated to dryness
- dissolutionthe crude material dissolved in DMSO
- custompurified by MDAP
Quellen und Nachweise
- ORD-Eintrag
- ord-eb0845f86c284cd9b0afbedca2514b98
- Quelldatensatz
- uspto-grants-2012_01
- Patentnummer
- US08093249B2
Notizen zur Reaktion
Wird geladen…